Effects of exercise training on the severity and composition of atherosclerotic plaque in apoE-deficient mice

Journal of Vascular Research

Volumn 48, Issue 4, 2011, Pages 347-356

  Kadoglou, Nikolaos P E ^a   Kostomitsopoulos, Nikolaos ^a   Kapelouzou, Alkistis ^a   Moustardas, Petros ^a   Katsimpoulas, Michalis ^a   Giagini, Athina ^a   Dede, Eleni ^a   Boudoulas, Harisios ^a   Konstantinides, Stavros ^c   Karayannacos, Panayotis E ^a   Liapis, Christos D ^b  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Atherosclerosis; Exercise; Matrix metalloproteinases; Plaque stability; Tissue inhibitor of metalloproteinases 1

Indexed keywords

APOLIPOPROTEIN E; COLLAGEN; ELASTIN; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXERCISE; FEMALE; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SITTING; TREADMILL EXERCISE;

ANIMALS; APOLIPOPROTEINS E; BODY WEIGHT; FEMALE; HEART RATE; LIPIDS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; PHYSICAL CONDITIONING, ANIMAL; PLAQUE, ATHEROSCLEROTIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 79952334186     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000321174     Document Type: Article

References (33)

1. Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, Liapis CD, Alevizos M: The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 2007;14: 837-843. (Pubitemid 350197015)
2. Nanni S, Melandri G, Hanemaaijer R, Cervi V, Tomasi L, Altimari A, Van Lent N, Tricoci P, Bacchi L, Branzi A: Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms. Transl Res 2007;149:137-144. (Pubitemid 46275571)
3. Okabe TA, Shimada K, Hattori M, Murayama T, Yokode M, Kita T, Kishimoto C: Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects. Cardiovasc Res 2007;74:537-545. (Pubitemid 46693709)
4. Kadoglou NP, Liapis CD: Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr Med Res Opin 2004;20:419-432. (Pubitemid 38525149)
5. Kadoglou NP, Daskalopoulou SS, Perrea D, Liapis CD: Matrix metalloproteinases and diabetic vascular complications. Angiology 2005;56:173-189. (Pubitemid 40404472)
6. Mackey AL, Donnelly AE, Swanton A, Murray F, Turpeenniemi-Hujanen T: The effects of impact and non-impact exercise on circulating markers of collagen remodelling in humans. J Sports Sci 2006;24:843-848. (Pubitemid 44044268)
7. -/- mice. Arterioscler Thromb Vasc Biol 2008;28:1421-1428.
8. Naura AS, Hans CP, Zerfaoui M, Errami Y, Ju J, Kim H, Matrougui K, Kim JG, Boulares AH: High-fat diet induces lung remodeling in ApoE-deficient mice:an association with an increase in circulatory and lung inflammatory factors. Lab Invest 2009;89:1243-12451.
9. Pynn M, Schäfer K, Konstantinides S, Halle M: Exercise training reduces neointimal growth and stabilizes vascular lesions developing after injury in apolipoprotein E-deficient mice. Circulation 2004;109:386-392. (Pubitemid 38133909)
10. Tangirala RK, Rubin EM, Palinski W: Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 1995;36:2320-2328.
11. Puglisi MJ, Fernandez ML: Modulation of C-reactive protein, tumor necrosis factor-α, and adiponectin by diet, exercise, and weight loss. J Nutr 2008;138:2293-2296.
12. 2+ entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovasc Res 2010;85:631-640.
13. Thorngate FE, Rudel LL, Walzem RL, Williams DL: Low levels of extrahepatic nonmacrophage apoE inhibit atherosclerosis without correcting hypercholesterolemia in apoE-deficient mice. Arterioscler Thromb Vasc Biol 2000;20:1939-1945. (Pubitemid 30644644)
14. Miyata M, Smith JD: Apolipoprotein E allele- specific antioxidant activity and effects on cytotoxicity by oxidative insults and β- amyloid peptides. Nat Genet 1996;14:55-61. (Pubitemid 26301547)
15. Zenovich AG, Panoskaltsis-Mortari A, Caron GJ, Kolb AG, Fremming R, Nelson WD, Taylor DA: Sex-based differences in vascular repair with bone marrow cell therapy: relevance of regulatory and Th2-type cytokines. Transplant Proc 2008;40:641-643. (Pubitemid 351406430)
16. Narula J, Garg P, Achenbach S, Motoyama S, Virmani R, Strauss HW: Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med 2008;5(suppl 2):S2-S10.
17. Verhamme P, Quarck R, Hao H, Knaapen M, Dymarkowski S, Bernar H, Van Cleemput J, Janssens S, Vermylen J, Gabbiani G, Kockx M, Holvoet P: Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs. Cardiovasc Res 2002;56:135-144. (Pubitemid 35247810)
18. Napoli C, Williams-Ignarro S, De Nigris F, Lerman LO, Rossi L, Guarino C, Mansueto G, Di Tuoro F, Pignalosa O, De Rosa G, Sica V, Ignarro LJ: Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc Natl Acad Sci USA 2004;101:8797-8802. (Pubitemid 38745851)
19. Ramachandran S, Penumetcha M, Merchant NK, Santanam N, Rong R, Parthasarathy S: Exercise reduces preexisting atherosclerotic lesions in LDL receptor knock out mice. Atherosclerosis 2005;178:33-38. (Pubitemid 39600813)
20. Shimada K, Kishimoto C, Okabe TA, Hattori M, Murayama T, Yokode M, Kita T: Exercise training reduces severity of atherosclerosis in apolipoprotein E knockout mice via nitric oxide. Circ J 2007;71:1147-1151. (Pubitemid 46998035)
21. Niebauer J, Maxwell AJ, Lin PS, Wang D, Tsao PS, Cooke JP: NOS inhibition accelerates atherogenesis:reversal by exercise. Am J Physiol Heart Circ Physiol 2003;285:H535-H540. (Pubitemid 36885883)
22. Cheng M, Hashmi S, Mao X, Zeng QT: Relationships of adiponectin and matrix metalloproteinase- 9 to tissue inhibitor of metalloproteinase- 1 ratio with coronary plaque morphology in patients with acute coronary syndrome. Can J Cardiol 2008;24:385-590.
23. Luttun A, Lutgens E, Manderveld A, Maris K, Collen D, Carmeliet P, Moons L: Loss of matrix metalloproteinase-9 or matrix metalloproteinase- 12 protects apolipoprotein Edeficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 2004;109:1408-1414. (Pubitemid 38387828)
24. Ding S, Zhang M, Zhao Y, Chen W, Yao G, Zhang C, Zhang P, Zhang Y: The role of carotid plaque vulnerability and inflammation in the pathogenesis of acute ischemic stroke. Am J Med Sci 2008;336:27-31.
25. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-2503. (Pubitemid 24379627)
26. Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PR, Thompson MM: Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 2000;31:40-47.
27. Becker JW, Marcy AI, Rokosz LL, Axel MG, Burbaum JJ, Fitzgerald PM, Cameron PM, Esser CK, Hagmann WK, Hermes JD, et al: Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Sci 1995;4:1966-1976.
28. Nabata A, Kuroki M, Ueba H, Hashimoto S, Umemoto T, Wada H, Yasu T, Saito M, Momomura S, Kawakami M: C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis 2008;196:129-135.
29. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM: IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995;96:2304-2310.
30. DeGraba TJ: Immunogenetic susceptibility of atherosclerotic stroke: implications on current and future treatment of vascular inflammation. Stroke 2004;35(suppl 1):2712-2719.
31. Gurjar MV, Sharma RV, Bhalla RC: eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler Thromb Vasc Biol 1999;19:2871-2877. (Pubitemid 30029812)
32. Roberts CK, Chen AK, Barnard RJ: Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors. Atherosclerosis 2007;191:98-106. (Pubitemid 46237630)
33. Turu MM, Krupinski J, Catena E, Rosell A, Montaner J, Rubio F, Alvarez-Sabin J, Cairols M, Badimon L: Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis 2006;187:161-169. (Pubitemid 43817009)